Morphogenesis of the vascular tree;LA MORPHOGENESE DE L'ARBRE VASCULAIRE. DE LA COMPREHENSION DES MECANISMES MOLECULAIRES AUX PERSPECTIVES THERAPEUTIQUES

Medecine/Sciences

Volumn 14, Issue 4, 1998, Pages 437-447

  Mattot, Virginie ^a   Pourtier, Albin ^b   Soncin, Fabrice ^d   Vandenbunder, Bernard ^c  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c INSTITUT DE BIOLOGIE DE LILLE   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BASEMENT MEMBRANE; CANCER THERAPY; CAPILLARY; HUMAN; METASTASIS; MORPHOGENESIS; NONHUMAN; PERICYTE; REVIEW; VASCULARIZATION;

EID: 0031942303     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1059     Document Type: Review

References (55)

1. Pardanaud L, Yassine F, Dieterlen-Lièvre F. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 1989 ; 105 : 473-85.
2. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995 ; 11 : 73-91.
3. Noden DM. Embryonic origins and assembly of blood vessels. Am Rev Respir Dis 1989 ; 140 : 1097-103.
4. Asahara T, Murohata T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbicher B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 ; 275 : 964-7.
5. Clark FR, Clark EL. Microscopic observations on the growth of blood capillaries in the living animal. Am J Anat 1938 ; 64 : 251-301.
6. Shi Y, O'Brien JE, Ala-Kokko L, Chung W, Mannion JD, Zalewski A. Origin of extracellular matrix synthesis during coronary repair. Cirulation 1997 ; 95 : 997-1006.
7. Kaiser D, Freyberg MA, Friedl P. Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem Biophys Res Commun 1997 ; 231 : 586-90.
8. Meeson A, Palmer M, Calfon M, Lang R. A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Development 1996; 122 : 3929-38.
9. Vaupel P, Schlenger K, Höckel M. Blood flow and tissue oxygenation of human tumors : an update. Adv Exp Med Biol 1992 ; 317 : 139-51.
10. Fan TPD, Brein S. Angiosuppersion in the search for new anticancer drugs. In : Waring MJ, Ponder BAJ, eds. Cancer biology and medicine. Amsterdam : Kluwer Academic Publisher, 1992.
11. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary brest cancer and its relation to angiogenesis. Cancer Res 1997 ; 57 : 963-9.
12. Moghaddam A, Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 1992 ; 31 : 1214-6.
13. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, Yamada Y. Angiogenic activity of enzymes. Nature 1994 ; 368 : 198.
14. Barleon B, Suzzani S, Zhou D, H.A. W, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996 ; 87 : 3336-43.
15. Senger DR. Molecular framework for angiogenesis. Am J Pathol 1996 ; 149 : 1-7.
16. Frelin C, Ladoux A, Bauters C, VEGF : médiateur de l'angiogenèse hypoxique. Med Sci 1997 ; 13 : 886-91.
17. Alon T, Hemo I, Itin A, Pe'er A, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has applications for retinopathy of prematurity. Nat Med 1995 ; 1 : 1024-8.
18. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an antivascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 1996 ; 93 : 14765-70.
19. Dumont D, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML. Vascularization of the mouse embryo : a sludy of flt-1, tek, tie and vascular endothelial growth factor expression during development. Dev Dynamics 1995 ; 203 : 80-92.
20. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995 ; 376 : 70-4.
21. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TK, Bruno J, Radziejewski C, Maisonpierre PC, Yankopoulos GD. Isolation of angiopoietin-1, a ligand for the Tie2 receptor by secretion-trap expression cloning. Cell 1996 ; 87 : 1161-9.
22. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of Angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell 1996 ; 87 : 1171-80.
23. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997 ; 277 : 55-60.
24. Ingber DE, Folkman J. Mechanochemical switching between growth and differentiation during Fibroblast Growth Factor-stimulated angiogenesis in vitro : role of the extracellular matrix. J Cell Biol 1989 ; 109 : 317-30.
25. Polverini PJ. Cellular adhesion molecules; newly identified mediators of angiogenesis. Am J Pathol 1996 ; 148 : 1023-9.
26. Clark RA, Tonnesen MG, Gailit J, Cheresh DA. Transient functional expression of alphaVbeta 3 on vascular cells during wound repair. Am J Pathol 1996 ; 148 : 1407-21.
27. Brooks PC, Strömblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. Auti-integrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995 ; 96 : 1815-22.
28. Brooks PC, Strömblad S, Sanders L, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996 ; 85 : 683-93.
29. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA. Regulation of integrin function by the urokinase receptor. Science 1996 ; 273 : 1551-5.
30. Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci USA 1997 ; 94 : 6273-8.
31. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 1996 ; 2 : 992-7.
32. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990 ; 248 : 1408-10.
33. Good DJ, Polverini PJ, Rastinejad F, LeBeau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is imnumologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990 ; 87 : 6624-8.
34. Van Meir E, Polverini PJ, Chazin VR, Su Huang H, de Tribolet N, Cavenec WK. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet 1994 ; 8 : 171-6.
35. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios C, Lane W, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin : an endogenous inhibitor af angiogenesis and tumor growth. Cell 1997 ; 88 : 277-85.
36. Clapp C, Martial JA, Guzman RC, Rentier DF, Weiner RI. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 1993 ; 133 : 1292-9.
37. Gupta SK, Hassel T, Singh JP. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci USA 1995 ; 92 : 7799-803.
38. D'Angelo G, Struman I, Martial J, Weiner RI. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 1995 ; 92 : 6374-8.
39. Dawson DW, Pearce FA, Zhong R, Silverstein RL, Frazier WA, Bouck NP. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 1997 ; 138 : 707-17.
40. Sin N, Meng L, Wang MQW, Wen JJ, Bornmann WG, Crews CM. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase. MetAP-2. Proc Natl Acad Sci USA 1997 ; 94 : 6099-103.
41. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997 ; 390 : 404-7.
42. Muthukkaruppan V, Auerbach R. Angiogenesis in mouse cornea. Science 1979 ; 205 : 1416-8.
43. Gingras D, Béliveau R. L'angiogenèse tumorale : une nouvelle cible thérapeutique anticancéreuse. Med Sci 1997 ; 13 : 1428-35.
44. Burrows FJ, Thorpe PE. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci USA 1993 ; 90 : 8996-9000.
45. Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 1997; 275 : 547-50.
46. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996 ; 2 : 689-92.
47. Klauber N, Rohan RM, Flynn E, D'Amato RJ. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med 1997 ; 3 : 443-6.
48. Jain RK. Delivery of molecular medicine to solid tumors. Science 1996 ; 271 : 1079-80.
49. Kakeji Y, Teicher BA. Preclinical studies of the combination of augiogenic inhibitors with cytotoxic agents. Invest New Drugs 1997 ; 15 : 39-48.
50. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997 ; 277 : 48-50.
51. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 1991 ; 51 : 6180-4.
52. Aiello LP, Pierce FA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growh factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995 ; 92 : 10457-61.
53. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk1 mutant. Nature 1994 ; 367 : 576-9.
54. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J. Synethetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990 ; 348 : 555-7.
55. Min HY, Doyle LV, Vitt CR, Zandonella GL, Stratton-Thomas JR, Shuman MA, Rosenberg S. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res 1996 ; 56 : 2428-33.